40 Epidemiologiske forsøg har vist, at langtidsbehandling med hydrochlorthiazid reducerer risikoen for kardiovaskulær mortalitet og morbiditet.
Epidemiological studies have shown that long-term treatment with hydrochlorothiazide reduces the risk of cardiovascular mortality and morbidity.